155 related articles for article (PubMed ID: 35440308)
21. The effects of olanzapine in reducing the emergence of psychosis among nursing home patients with Alzheimer's disease.
Clark WS; Street JS; Feldman PD; Breier A
J Clin Psychiatry; 2001 Jan; 62(1):34-40. PubMed ID: 11235926
[TBL] [Abstract][Full Text] [Related]
22. Principles and management of neuropsychiatric symptoms in Alzheimer's dementia.
Nowrangi MA; Lyketsos CG; Rosenberg PB
Alzheimers Res Ther; 2015 Jan; 7(1):12. PubMed ID: 27391771
[TBL] [Abstract][Full Text] [Related]
23. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation.
Holmes C; Smith H; Ganderton R; Arranz M; Collier D; Powell J; Lovestone S
J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):777-9. PubMed ID: 11723200
[TBL] [Abstract][Full Text] [Related]
24. Delusions and hallucinations in Alzheimer's disease: prevalence and clinical correlates.
Bassiony MM; Steinberg MS; Warren A; Rosenblatt A; Baker AS; Lyketsos CG
Int J Geriatr Psychiatry; 2000 Feb; 15(2):99-107. PubMed ID: 10679840
[TBL] [Abstract][Full Text] [Related]
25. Psychotic symptoms in Alzheimer's disease are not influenced by polymorphic variation at the dopamine receptor DRD3 gene.
Craig D; Hart DJ; Carson R; McIlroy SP; Passmore AP
Neurosci Lett; 2004 Sep; 368(1):33-6. PubMed ID: 15342129
[TBL] [Abstract][Full Text] [Related]
26. The Role of Cerebrovascular Disease on Cognitive and Functional Status and Psychosis in Severe Alzheimer's Disease.
Kim J; Schweizer TA; Fischer CE; Munoz DG
J Alzheimers Dis; 2017; 55(1):381-389. PubMed ID: 27662301
[TBL] [Abstract][Full Text] [Related]
27. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
Fischer CE; Ismail Z; Youakim JM; Creese B; Kumar S; Nuñez N; Ryan Darby R; Di Vita A; D'Antonio F; de Lena C; McGeown WJ; Ramit R; Rasmussen J; Bell J; Wang H; Bruneau MA; Panegyres PK; Lanctôt KL; Agüera-Ortiz L; Lyketsos C; Cummings J; Jeste DV; Sano M; Devanand DP; Sweet RA; Ballard C
J Alzheimers Dis; 2020; 73(3):1143-1156. PubMed ID: 31884469
[TBL] [Abstract][Full Text] [Related]
28. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
Kashihara K; Ohno M; Katsu Y
Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis.
Kulick CV; Montgomery KM; Nirenberg MJ
Parkinsonism Relat Disord; 2018 Sep; 54():40-45. PubMed ID: 29653909
[TBL] [Abstract][Full Text] [Related]
30. An instrumental study of the relationship between extrapyramidal signs and psychosis in Alzheimer's disease.
Caligiuri MP; Peavy G
J Neuropsychiatry Clin Neurosci; 2000; 12(1):34-9. PubMed ID: 10678510
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the G720/G30 gene locus (DAOA) influences the occurrence of psychotic symptoms in patients with Alzheimer's disease.
Di Maria E; Bonvicini C; Bonomini C; Alberici A; Zanetti O; Gennarelli M
J Alzheimers Dis; 2009; 18(4):953-60. PubMed ID: 20009237
[TBL] [Abstract][Full Text] [Related]
32. Presenilin Gene Mutation-associated Psychosis: Phenotypic Characteristics and Clinical Implications.
Colijn MA; Ismail Z
Alzheimer Dis Assoc Disord; 2024 Jan-Mar 01; 38(1):101-106. PubMed ID: 38227890
[TBL] [Abstract][Full Text] [Related]
33. Overview of depression and psychosis in Alzheimer's disease.
Wragg RE; Jeste DV
Am J Psychiatry; 1989 May; 146(5):577-87. PubMed ID: 2653053
[TBL] [Abstract][Full Text] [Related]
34. The Neuropsychological Profile and Phenomenology of Late Onset Psychosis: A Cross-sectional Study on the Differential Diagnosis of Very-Late-Onset Schizophrenia-Like Psychosis, Dementia with Lewy Bodies and Alzheimer's Type Dementia with Psychosis.
Van Assche L; Van Aubel E; Van de Ven L; Bouckaert F; Luyten P; Vandenbulcke M
Arch Clin Neuropsychol; 2019 Mar; 34(2):183-199. PubMed ID: 29635309
[TBL] [Abstract][Full Text] [Related]
35. The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: persistence and new cases over 1 year of follow-up.
Ballard CG; O'Brien JT; Swann AG; Thompson P; Neill D; McKeith IG
J Clin Psychiatry; 2001 Jan; 62(1):46-9. PubMed ID: 11235928
[TBL] [Abstract][Full Text] [Related]
36. Neuropsychiatric symptoms in the dementias.
Assal F; Cummings JL
Curr Opin Neurol; 2002 Aug; 15(4):445-50. PubMed ID: 12151841
[TBL] [Abstract][Full Text] [Related]
37. Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.
Kim J; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2017; 14(8):834-840. PubMed ID: 28219318
[TBL] [Abstract][Full Text] [Related]
38. How to manage depression and psychosis in Alzheimer's disease.
Tueth MJ
Geriatrics; 1995 Jan; 50(1):43-6, 49. PubMed ID: 7821828
[TBL] [Abstract][Full Text] [Related]
39. Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms.
Fénelon G
CNS Spectr; 2008 Mar; 13(3 Suppl 4):18-25. PubMed ID: 18323763
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.
Ballard C; Banister C; Khan Z; Cummings J; Demos G; Coate B; Youakim JM; Owen R; Stankovic S;
Lancet Neurol; 2018 Mar; 17(3):213-222. PubMed ID: 29452684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
